Literature DB >> 22986531

Regulation of the tumor suppressor homeogene Cdx2 by HNF4α in intestinal cancer.

T Saandi1, F Baraille, L Derbal-Wolfrom, A-L Cattin, F Benahmed, E Martin, P Cardot, B Duclos, A Ribeiro, J-N Freund, I Duluc.   

Abstract

The gut-specific homeotic transcription factor Cdx2 is a crucial regulator of intestinal development and homeostasis, which is downregulated in colorectal cancers (CRC) and exhibits a tumor suppressor function in the colon. We have previously established that several endodermal transcription factors, including HNF4α and GATA6, are involved in Cdx2 regulation in the normal gut. Here we have studied the role of HNF4α in the mechanism of deregulation of Cdx2 in colon cancers. Crossing Apc(Δ14/+) mice prone to spontaneous intestinal tumor development with pCdx2-9LacZ transgenic mice containing the LacZ reporter under the control of the 9.3-kb Cdx2 promoter showed that this promoter segment contains sequences recapitulating the decrease of Cdx2 expression in intestinal cancers. Immunohistochemistry revealed that HNF4α, unlike GATA6, exhibited a similar decrease to Cdx2 in genetic (Apc(min/+) and Apc(Δ14/+)) and chemically induced (Azoxymethane (AOM) treatment) models of intestinal tumors in mice. HNF4α and Cdx2 also exhibited a comparable deregulated pattern in human CRC. Correlated patterns were observed between HNF4α and Cdx2 in several experimental models of human colon cancer cell lines: xenografts in nude mice, wound healing and glucose starvation. Furthermore, Cdx2 decreased by knocking down HNF4α in human colon cancer cells using siRNA and in the colon of mice conditionally knocked out for the Hnf4α gene in the adult intestine (Hnf4α(f/f);VilCre(ERT2) mice). Finally, the conditionally knocked out mice Hnf4α(f/f);VilCre(ERT2) treated with the carcinogen AOM developed colorectal tumors earlier than wild-type mice, as previously reported for mice with a reduced Cdx2 expression. In conclusion, this study provides evidence that the downregulation of HNF4α is an important determinant of the reduced expression of the Cdx2 tumor suppressor gene in intestinal cancers. Consistently, similar to Cdx2, HNF4α exerts a tumor suppressor function in the colon in that its loss of function facilitates tumor progression.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22986531     DOI: 10.1038/onc.2012.401

Source DB:  PubMed          Journal:  Oncogene        ISSN: 0950-9232            Impact factor:   9.867


  23 in total

1.  Loss of CDX2 expression is associated with poor prognosis in colorectal cancer patients.

Authors:  Jeong Mo Bae; Tae Hun Lee; Nam-Yun Cho; Tae-You Kim; Gyeong Hoon Kang
Journal:  World J Gastroenterol       Date:  2015-02-07       Impact factor: 5.742

2.  Opposing roles of nuclear receptor HNF4α isoforms in colitis and colitis-associated colon cancer.

Authors:  Karthikeyani Chellappa; Poonamjot Deol; Jane R Evans; Linh M Vuong; Gang Chen; Nadege Briançon; Eugene Bolotin; Christian Lytle; Meera G Nair; Frances M Sladek
Journal:  Elife       Date:  2016-05-11       Impact factor: 8.140

3.  TGR5-HNF4α axis contributes to bile acid-induced gastric intestinal metaplasia markers expression.

Authors:  Zhen Ni; Yali Min; Chuan Han; Ting Yuan; Wenquan Lu; Hassan Ashktorab; Duane T Smoot; Qiong Wu; Jian Wu; Weizheng Zeng; Yongquan Shi
Journal:  Cell Death Discov       Date:  2020-07-06

Review 4.  Nuclear receptors in cancer - uncovering new and evolving roles through genomic analysis.

Authors:  Vineet K Dhiman; Michael J Bolt; Kevin P White
Journal:  Nat Rev Genet       Date:  2017-12-27       Impact factor: 53.242

5.  A novel mouse model of sporadic colon cancer induced by combination of conditional Apc genes and chemical carcinogen in the absence of Cre recombinase.

Authors:  Jeffrey S Souris; Hannah J Zhang; Urszula Dougherty; Nai-Tzu Chen; Joseph V Waller; Leu-Wei Lo; John Hart; Chin-Tu Chen; Marc Bissonnette
Journal:  Carcinogenesis       Date:  2019-11-25       Impact factor: 4.944

6.  HNF4α-Deficient Fatty Liver Provides a Permissive Environment for Sex-Independent Hepatocellular Carcinoma.

Authors:  Baharan Fekry; Aleix Ribas-Latre; Corrine Baumgartner; Alaa M T Mohamed; Mikhail G Kolonin; Frances M Sladek; Mamoun Younes; Kristin L Eckel-Mahan
Journal:  Cancer Res       Date:  2019-10-01       Impact factor: 12.701

7.  Fine-tuning and autoregulation of the intestinal determinant and tumor suppressor homeobox gene CDX2 by alternative splicing.

Authors:  Camille Balbinot; Marie Vanier; Olivier Armant; Asmaa Nair; Julien Penichon; Christine Soret; Elisabeth Martin; Thoueiba Saandi; Jean-Marie Reimund; Jacqueline Deschamps; Felix Beck; Claire Domon-Dell; Isabelle Gross; Isabelle Duluc; Jean-Noël Freund
Journal:  Cell Death Differ       Date:  2017-09-01       Impact factor: 15.828

8.  Overexpression of hepatocyte nuclear factor 4α in human mesenchymal stem cells suppresses hepatocellular carcinoma development through Wnt/β-catenin signaling pathway downregulation.

Authors:  Ning Wu; Yu-Ling Zhang; Hai-Tian Wang; Da-Wei Li; Hui-Juan Dai; Qi-Qi Zhang; Jiang Zhang; Yong Ma; Qiang Xia; Jian-Min Bian; Hua-Lian Hang
Journal:  Cancer Biol Ther       Date:  2016-05-03       Impact factor: 4.742

9.  Epigenetic control of HNF-4α in colon carcinoma cells affects MUC4 expression and malignancy.

Authors:  Anna Algamas-Dimantov; Einav Yehuda-Shnaidman; Irena Peri; Betty Schwartz
Journal:  Cell Oncol (Dordr)       Date:  2013-01-11       Impact factor: 6.730

10.  MicroRNA-766-3p-mediated downregulation of HNF4G inhibits proliferation in colorectal cancer cells through the PI3K/AKT pathway.

Authors:  Xin-Xin He; Shan-Shan Luo; Hai-Quan Qin; Xian-Wei Mo
Journal:  Cancer Gene Ther       Date:  2021-06-22       Impact factor: 5.854

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.